tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Editas Medicine (EDIT) Similar Stocks

Compare
3,434 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$1.56
$111.33M
-72.14%
3 Buy
5 Hold
1 Sell
Hold
Cellectis SA
$1.44
$111.87M
-45.04%
2 Buy
0 Hold
0 Sell
Moderate Buy
RAPT Therapeutics
$0.78
$103.23M
-89.74%
2 Buy
1 Hold
0 Sell
Moderate Buy
Nkarta
$1.85
$111.76M
-69.96%
6 Buy
0 Hold
0 Sell
Strong Buy
Neumora Therapeutics, Inc.
$0.66
$106.75M
-93.23%
3 Buy
3 Hold
1 Sell
Moderate Buy
Contineum Therapeutics, Inc. Class A
$4.95
$128.06M
-69.20%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
1.56
-3.90
-71.43%
CLLS
Cellectis SA
1.44
-1.18
-45.04%
RAPT
RAPT Therapeutics
0.82
-7.18
-89.75%
NKTX
Nkarta
2.22
-5.34
-70.63%
NMRA
Neumora Therapeutics, Inc.
0.70
-9.60
-93.20%
CTNM
Contineum Therapeutics, Inc. Class A
4.90
-11.01
-69.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis